ESMO Open Oncology

Pembrolizumab plus FLOT as neoadjuvant and adjuvant therapy in locally advanced gastric and gastroesophageal junction cancer: analysis of the FLOT cohort from the phase 3 KEYNOTE-585 study

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →